FSD Pharma (HUGE) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock HUGE Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Quantum BioPharma to be in court with Raza Bokhari on January 24January 17, 2025 | markets.businessinsider.comU.S. election: Tesla and the EV sector are on watch for volatility this weekNovember 3, 2024 | msn.comNvidia: Self-Driving Vehicles Are An Important Proof PointOctober 31, 2024 | seekingalpha.comIt's Time To Buy Baidu AgainOctober 25, 2024 | seekingalpha.comTesla: Q3 Deliveries Not Bad At AllOctober 8, 2024 | seekingalpha.comTesla: Ignore The Delivery Miss Noise, Focus On 'We, Robot'October 3, 2024 | seekingalpha.comWhat Seeking Alpha analysts think about the Tesla robotaxi eventOctober 3, 2024 | seekingalpha.comEV watch: Tesla deliveries, robotaxi musings, and soaring deliveries in ChinaOctober 1, 2024 | seekingalpha.comTesla Is Ready To Complete A Cup And Handle, And Continue This Breakout (Technical Analysis)September 25, 2024 | seekingalpha.comFTC head Lina Khan fighting Big Tech, Big Pharma and Big GroceriesSeptember 24, 2024 | msn.comFederal regulator hauls huge drug middlemen into court over insulin pricesSeptember 24, 2024 | yahoo.comTesla falls 6% as investors weigh robotaxi developmentsAugust 22, 2024 | msn.comWhy FSD Pharma Stock Is Seeing Huge GainsAugust 9, 2024 | benzinga.comFSD Pharma Inc (0K9.MU)July 21, 2024 | nz.finance.yahoo.comBig Pharma’s focus on profit is behind medicine shortages, superbug threatMay 28, 2024 | msn.comMedicus Pharma eyes IPO with 'groundbreaking' SkinJect patch in the pipelineMay 13, 2024 | bizjournals.comU.S. factory orders rise 1.6% M/M in March, meeting consensusMay 2, 2024 | msn.comMerck Stock Jumps After Dow Jones Stalwart Rides Its Cancer 'Star' To Another Quarterly BeatApril 26, 2024 | msn.comFSD Pharma Provides Update from Celly Nu’s Partnership with Six+One for unbuzzd(TM)April 25, 2024 | finance.yahoo.comFSD Pharma Inc.: FSD Pharma Expands Investigative Pipeline to Include Potential Weight Loss and Liver Health Formulations and ProductsApril 17, 2024 | finanznachrichten.deFSD Pharma Expands Investigative Pipeline to Include Potential Weight Loss and Liver Health Formulations and ProductsApril 17, 2024 | finance.yahoo.comSam Bankman-Fried gets 25 years in prison for fraud and money laundering at FTX, ordered to pay $11B in forfeitureMarch 30, 2024 | techcrunch.comTHUGE Apr 2024 2.000 putMarch 16, 2024 | finance.yahoo.comFSD Pharma Inc.: FSD Pharma Announces Debt SettlementFebruary 28, 2024 | finanznachrichten.deBiotech Company Develops Inebriation Remedy Beverage 'UNBUZZD'February 26, 2024 | msn.comFSD Pharma Provides Update on Proposed Dividend Distribution for Shareholders of FSD Pharma to Receive Shares of Celly Nutrition on a One for One BasisNovember 7, 2023 | finance.yahoo.comFSD Pharma announces Interim Results from First-in-Human Clinical Trial of Lucid-MS (Lucid-21-302) for Multiple Sclerosis; The Report Shows Compound to be Safe and Well ToleratedSeptember 18, 2023 | finance.yahoo.comFSD Pharma Selected to Present its Phase 1 Data on Lucid-MS at MSMilan 2023 – 9th Joint ECTRIMS-ACTRIMS Meeting for October 11-13, 2023August 15, 2023 | finance.yahoo.comInvestmentPitch Media Video Features FSD Pharma’s Definitive Agreement Granting Exclusive Rights for Launch of UNBUZZD, a Revolutionary Rapid Alcohol Detoxification DrinkAugust 3, 2023 | finance.yahoo.comInvestmentPitch Media Video Discusses FSD Pharma’s Granting of Exclusive Rights to Revolutionary Recreational Alcohol Misuse Technology to Celly NutritionJune 23, 2023 | finance.yahoo.comFSD Pharma Announces Agreement To Grant Exclusive Rights To Recreational Alcohol Misuse TechnologyJune 20, 2023 | msn.comFSD Pharma Announces Agreement to Grant Exclusive Rights to Revolutionary Recreational Alcohol Misuse TechnologyJune 20, 2023 | finance.yahoo.comFSD Pharma Appoints Former Ontario Minister of Health Doctor Eric Hoskins to Board of DirectorsMay 25, 2023 | finance.yahoo.comFSD Pharma Inc. (HUGE.CN)May 13, 2023 | finance.yahoo.comFSD Pharma Awarded $2.81 Million in Cost Awards From Dr. Raza BokhariMay 11, 2023 | finance.yahoo.comPromising Multiple Sclerosis Drug Candidate Advances: First Clinical Trial Dosing CompletedMay 10, 2023 | msn.comFSD Pharma Completes Dosing of First Cohort in Phase I Clinical Trial of Lucid-MS, a New Drug Candidate for the Treatment of Multiple Sclerosis: Safety Review Committee Recommends Commencing Dosing of Second CohortMay 10, 2023 | finance.yahoo.comDynamic Duo of Celsius Holdings Fame join FSD Pharma calling Medical Product under Development "Unique and Disruptive"April 19, 2023 | benzinga.comFSD Pharma Announces Plan to Spin-Out Subsidiary as Distribution to Shareholders; Shareholder Meeting Scheduled for June 29, 2023April 12, 2023 | finance.yahoo.comIIROC Trading Halt - HUGEApril 12, 2023 | finance.yahoo.comIIROC Trade Resumption - HUGEApril 12, 2023 | finance.yahoo.comFSD Pharma Presenting Two Scientific Posters on Preclinical Toxicology and Efficacy Data of Lucid-21-302 (Lucid-MS) at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2023 ForumFebruary 21, 2023 | finance.yahoo.comFSD Pharma Regains Compliance with NASDAQ Continued Listing RequirementsFebruary 15, 2023 | finance.yahoo.comFSD Pharma receives regulatory clearance for proposed Phase 1 clinical trial of multiple sclerosis drug candidate Lucid-MSFebruary 7, 2023 | proactiveinvestors.comFSD Pharma submits clinical trial application for its multiple sclerosis treatment candidate Lucid-MSJanuary 17, 2023 | proactiveinvestors.comFSD Pharma submits its phase-1 Clinical Trial Application for Lucid-MS (Lucid-21-302) for first-in-human safety and tolerability investigationJanuary 17, 2023 | finance.yahoo.comTesla, Zillow, Albireo Pharma And Some Other Big Stocks Moving Higher On MondayJanuary 9, 2023 | msn.comFSD Pharma incorporates new subsidiary to capitalize on drug development incentives in AustraliaJanuary 9, 2023 | proactiveinvestors.comFSD Pharma Inc Incorporates New Subsidiary to Capitalize on Drug Development Incentives in AustraliaJanuary 9, 2023 | financialpost.comFFSD Pharma to Attend 41st Annual J.P. Morgan Healthcare Conference 2023January 6, 2023 | finance.yahoo.com Get FSD Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for HUGE and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. HUGE Media Mentions By Week HUGE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HUGE News Sentiment▼0.001.00▲Average Computer and Technology News Sentiment HUGE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HUGE Articles This Week▼00▲HUGE Articles Average Week Get the Latest News and Ratings for HUGE and Related Stocks Enter your email address to receive the latest news and analysts' ratings for FSD Pharma and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies SHOP News CSU News OTEX News DSG News KXS News LSPD News ENGH News DCBO News DND News BLN News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CNSX:HUGE) was last updated on 9/2/2025 by MarketBeat.com Staff From Our Partners[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredI’d rather trade news like this than gamble on hypeReal traders are watching Nvidia’s next move—after U.S. approval to resume chip sales to China. This reversal ...Timothy Sykes | SponsoredAmerica Betrayed Porter Stansberry says he got one thing wrong—and now millions of Americans could pay the price. After warning...Porter & Company | Sponsored6-Figure Target for BTC by 2025Crypto ETF records broken – here's what’s next The biggest names in finance have built the infrastructure f...Crypto 101 Media | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FSD Pharma Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share FSD Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.